Bristol Myers raises revenue guidance for the year, prepares for major Cobenfy readouts

Bristol Myers Squibb is upping its revenue guidance for 2025 by $700 million. The pharma company said Thursday that it now expects to bring in between $46.5 billion and $47.5 billion ...